Blocking tri-methylguanosine synthase 1 (TGS1) stops anchorage-independent growth of canine sarcomas
Cancer Gene Therapy, Published online: 29 June 2023; doi:10.1038/s41417-023-00636-9Blocking tri-methylguanosine synthase 1 (TGS1) stops anchorage-independent growth of canine sarcomas (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 29, 2023 Category: Cancer & Oncology Authors: Dora Zucko Kathleen Boris-Lawrie Source Type: research

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
Cancer Gene Therapy, Published online: 23 June 2023; doi:10.1038/s41417-023-00637-8Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 23, 2023 Category: Cancer & Oncology Authors: Caterina Mancarella Veronica Giusti Giulia Caldoni Maria Antonella Laginestra Alessandro Parra Lisa Toracchio Giorgia Giordano Laura Roncuzzi Manuela Piazzi William Blalock Marta Columbaro Alessandra De Feo Katia Scotlandi Source Type: research

Small extracellular vesicle TGF-β in cancer progression and immune evasion
Cancer Gene Therapy, Published online: 21 June 2023; doi:10.1038/s41417-023-00638-7Small extracellular vesicle TGF-β in cancer progression and immune evasion (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 21, 2023 Category: Cancer & Oncology Authors: Reza Hosseini Nashmin Hosseinzadeh Leila Asef-Kabiri Atieh Akbari Behrooz Ghezelbash Hamzeh Sarvnaz Mohammad Esmaeil Akbari Source Type: research

Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures
Cancer Gene Therapy, Published online: 09 June 2023; doi:10.1038/s41417-023-00632-zProduction of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 9, 2023 Category: Cancer & Oncology Authors: Kevin P. Labadie Shannon A. Kreuser Katherine J. Brempelis Sara K. Daniel Xiuyun Jiang Kevin M. Sullivan Alan F. Utria Heidi L. Kenerson Teresa S. Kim Courtney A. Crane Venu G. Pillarisetty Source Type: research

ANRIL promotes the regulation of colorectal cancer on lymphatic endothelial cells via VEGF-C and is the key target for Pien Tze Huang to inhibit cancer metastasis
Cancer Gene Therapy, Published online: 07 June 2023; doi:10.1038/s41417-023-00635-wANRIL promotes the regulation of colorectal cancer on lymphatic endothelial cells via VEGF-C and is the key target for Pien Tze Huang to inhibit cancer metastasis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 7, 2023 Category: Cancer & Oncology Authors: Bin Huang Yao Lu Zhuona Ni Jinhong Liu Yanbin He Honglin An Feimin Ye Jiayu Shen Minghe Lin Yong Chen Jiumao Lin Source Type: research

Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways
Cancer Gene Therapy, Published online: 02 June 2023; doi:10.1038/s41417-023-00633-yMulti-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 2, 2023 Category: Cancer & Oncology Authors: In-Chi Young Thomas Brabletz Linsey E. Lindley Maria Abreu Nagaraj Nagathihalli Alexander Zaika Karoline J. Briegel Source Type: research

Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway
Cancer Gene Therapy, Published online: 31 May 2023; doi:10.1038/s41417-023-00634-xLong noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 31, 2023 Category: Cancer & Oncology Authors: Jingjing Miao Boyu Chen Yunyun Xiao Runda Huang Xiao Xiao Shunzhen Lu Lu Zhang Xuguang Wang Ying Ouyang Xiangfu Chen Qiuyan Chen Yanqun Xiang Xiang Guo Xiaowu Deng Lin Wang Haiqiang Mai Chong Zhao Source Type: research

P38 kinase in gastrointestinal cancers
Cancer Gene Therapy, Published online: 29 May 2023; doi:10.1038/s41417-023-00622-1P38 kinase in gastrointestinal cancers (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 29, 2023 Category: Cancer & Oncology Authors: Thuy Phan Xu Hannah Zhang Steven Rosen Laleh G. Melstrom Source Type: research

c-Myc-induced long noncoding RNA MIRE cooperates with hnRNPK to stabilize ELF2 mRNA and promotes clear cell renal cell carcinogenesis
Cancer Gene Therapy, Published online: 29 May 2023; doi:10.1038/s41417-023-00631-0c-Myc-induced long noncoding RNA MIRE cooperates with hnRNPK to stabilize ELF2 mRNA and promotes clear cell renal cell carcinogenesis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 29, 2023 Category: Cancer & Oncology Authors: Bingyan Li Bo Yao Xiaorui Guo Zhongyu Wang Wei Xie Xianning Wu Fang Wang Yide Mei Source Type: research

WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer
Cancer Gene Therapy, Published online: 29 May 2023; doi:10.1038/s41417-023-00626-xWWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 29, 2023 Category: Cancer & Oncology Authors: Karim Taouis Sophie Vacher Jos ée Guirouilh-Barbat Jacques Camonis Etienne Formstecher Tatiana Popova Anne-Sophie Hamy Ambre Petitalot Rosette Lidereau Sandrine M. Caputo Sophie Zinn-Justin Ivan Bi èche Keltouma Driouch Fran çois Lallemand Source Type: research

Retraction Note: circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2
Cancer Gene Therapy, Published online: 29 May 2023; doi:10.1038/s41417-023-00630-1Retraction Note: circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 29, 2023 Category: Cancer & Oncology Authors: Rui Xin Danhua Qu Huiying Xu Dawei Chen Source Type: research

Extracellular vesicles released by glioma cells are decorated by Annexin A2 allowing for cellular uptake via heparan sulfate
Cancer Gene Therapy, Published online: 25 May 2023; doi:10.1038/s41417-023-00627-wExtracellular vesicles released by glioma cells are decorated by Annexin A2 allowing for cellular uptake via heparan sulfate (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 25, 2023 Category: Cancer & Oncology Authors: Yu-xi Song Xin Li Sheng-dan Nie Zhong-xu Hu Di Zhou Ding-ya Sun Gao-ya Zhou Ying Wang Jia-jia Liu Tao Song Shan Wang Source Type: research

Inducible TgfbR1 and Pten deletion in a model of tongue carcinogenesis and chemoprevention
Cancer Gene Therapy, Published online: 25 May 2023; doi:10.1038/s41417-023-00629-8Inducible TgfbR1 and Pten deletion in a model of tongue carcinogenesis and chemoprevention (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 25, 2023 Category: Cancer & Oncology Authors: Felipe F. Lamenza Nathan M. Ryan Puja Upadhaya Arham Siddiqui Pete P. Jordanides Anna Springer Peyton Roth Hasan Pracha O. Hans Iwenofu Steve Oghumu Source Type: research

FIT links c-Myc and P53 acetylation by recruiting RBBP7 during colorectal carcinogenesis
Cancer Gene Therapy, Published online: 24 May 2023; doi:10.1038/s41417-023-00624-zFIT links c-Myc and P53 acetylation by recruiting RBBP7 during colorectal carcinogenesis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 24, 2023 Category: Cancer & Oncology Authors: Lili Guo Yang Xia Hao Li Zifei Wang Hui Xu Xiangyu Dai Yaqin Zhang Hao Zhang Wenhu Fan Feng Wei Qun Li Ling Zhang Limian Cao Shangxin Zhang Wanglai Hu Hao Gu Source Type: research

TMTC1 promotes invasiveness of ovarian cancer cells through integrins β1 and β4
Cancer Gene Therapy, Published online: 23 May 2023; doi:10.1038/s41417-023-00625-yTMTC1 promotes invasiveness of ovarian cancer cells through integrins β1 and β4 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 23, 2023 Category: Cancer & Oncology Authors: Ting-Chih Yeh Neng-Yu Lin Chin-Yu Chiu Tzu-Wen Hsu Hsin-Yi Wu Hsuan-Yu Lin Chi-Hau Chen Min-Chuan Huang Source Type: research